The infusion takes about 45 minutes. The recovery takes a season. After a systemic IV, many patients feel an early lift in sleep and energy within the first few weeks, though when it lands varies from person to person, then a continued build that peaks around 12 to 16 weeks, with improvement that can keep building through the first year.
A direct joint or spine injection runs a different early course, soreness first, on its own clock. The hardest part is usually neither the procedure nor the result. It's the wait between the lift and the signal.
The procedure is the easy part. The middle is the hard part.
The infusion is about 45 minutes in a chair, and an IV-only day is about 2 hours at the hospital. The hospital day is built around the watch: pre-medication, the line, the slow push, observation, a coffee from the on-site café, a walk to the car. Patients tend to over-estimate the difficulty of the procedure and under-estimate the difficulty of the recovery. The truth is closer to the inverse. The procedure is, in the modern era, dull. (We mean that as a compliment.) The recovery is where the work happens.
Your physicians, your nurses, the pharmacy, the hospital pager system. The hardest part is usually the IV start.
Bring loose clothing, patience for the middle, and a companion if you'd like one.
The first few weeks, for many patients, bring an early lift: sleep improves first (deeper, less interrupted), and daytime energy follows, though the exact timing differs from one patient to the next. A very small number of patients feel a mild flu-like reaction in the first 24 to 72 hours; that side effect is real but transient. It passes.
Plan light days; the lift is real but not the whole response.
If your protocol also includes a direct joint or spine injection, the early days run differently there: the injection site is usually sore before it settles, and almost everyone who gets an injection also gets the IV.
A spine injection usually means about a week of soreness and then normal activity; a knee, hip, ankle or foot injection means staying off that joint with very limited activity for the first 7 to 10 days. After a shoulder or hand injection, walking and light daily use are fine while you protect the joint for 7 to 10 days. Physical therapy starts after that.
Weeks two through eight are quieter on the validated-score front: pain and function don't typically inflect until later, though a few patients see a large response early. This is where most patients begin to worry that the therapy did not work. It is also, usually, when it is working most. The body is doing repair on a timeline of weeks, not minutes.
Early lift, continued build, and the durable response.
12–16 wk. When the response to an IV peaks. Improvement can keep building through the first year
Many patients feel an early lift in sleep and energy within the first few weeks, though the exact week varies, continue to build through the second month, and then see the validated clinical signal (pain, function) inflect between months two and four, with the response peaking around 12 to 16 weeks and slower, continued improvement for many patients through the first year.
Direct-injection patients start instead with soreness at the treated site and respond on their own site-dependent clock, with a first change usually between weeks 4 and 12 (the spine slowest), and nearly always receive the IV alongside the injection. The climb is rarely a moment; the big change is usually noticed in retrospect.
Not every patient gets a quiet climb. We will not pretend otherwise on the months when it would help our marketing to do so. The honest sentence at month six is the one we put in the chart.
Patient recover rest trust the build
Caregiver advocate log symptoms notice the change
One shared log, every day, both hands.
The clearest view is from the other chair.
The people in the room are the ones who see it working first. The changes build gradually, deeper sleep, steadier energy, an easier morning, and they range from small day-to-day shifts to substantial gains over the months, but the patient, focused on their own recovery, is usually the last to register them. The spouse, the sibling, the friend in the next chair notices the shift before the patient names it.
The spouse, or sibling, or adult child, whoever travels with the patient, has the role that matters most here. The patient has one task: recover. The caregiver has three: advocate with the medical team, log the symptoms the patient won't log, and notice the improvements, gradual and sometimes large, that the patient is too close to see. If someone comes with you, bring someone who pays attention. A companion is welcome, never required.
The caregiver section of this library exists because we have watched, for years, the families who learned to track those changes as they accumulate, and that attention, not the medicine alone, is part of what makes the difference.
58 yrs. Since the cell was first isolated in a laboratory, quiet, compounding. Friedenstein, 1968 · USSR Academy of Sciences
The first MSCs were isolated in a Soviet lab in 1968. The cells were not given the name they carry today until 1991, when Arnold Caplan called them mesenchymal stem cells. The standard definition came in 2006. The modern cGMP era is younger than most of the patients we treat. This is a field that has worked, quietly, for sixty years. The history matters most on the days the middle is hardest.
Each article stands alone. Read in sequence they describe a season: the arc, the companion, the line the patient sometimes does not want to hear, and the sixty-year history that made any of this possible. Start anywhere.
A six-month arc can be described by what usually happens. It can also be described, more usefully, by what we will not pretend happens. Four claims we do not let the marketing make about the patient experience.
Many patients feel something within the first weeks: better sleep first, then more daytime energy. What you will not feel that early is the validated clinical change in pain or function. That part is on a different clock. Measure quarter-to-quarter. The marketing page that promises the whole response by day seven is selling certainty, which is not on the menu.
The arc described in the recovery timeline is a median. Not every patient follows it. Some climb faster and earlier; some never get the climb at all. We can tell you the distribution. We cannot tell you, on day zero, which point on the distribution is yours. A clinic that tells you that is reading you a script.
Some patients report modest improvement at month six, less than they had hoped for. A smaller number get nothing measurable. We log those outcomes in the same chart as everyone else's, and we describe them in the same language. “It did not work as we'd hoped” is a sentence we have written, in full, more than once.
MSCs are not a substitute for sleep, exercise, diet, the medications on the patient's existing chart, or the difficult conversations with the referring physician. They are an input, not a strategy. The patients who do best are usually the ones who were already doing the boring things. We will say so on the call, and we will say so again at month one.